Mp61-03 comparing the outcomes of robotic assisted radical prostatectomy in black and white men: experience of a high-volume center

You have accessJournal of UrologyCME1 Apr 2023MP61-03 COMPARING THE OUTCOMES OF ROBOTIC ASSISTED RADICAL PROSTATECTOMY IN BLACK AND WHITE MEN: EXPERIENCE OF A HIGH-VOLUME CENTER Jonathan Noel, Marcio Moschovas, Abdel Rahman Jaber, Marco Sandri, Travis Rogers, and Vipul Patel Jonathan NoelJonathan Noel More articles by this author , Marcio MoschovasMarcio Moschovas More articles by this author , Abdel Rahman JaberAbdel Rahman Jaber More articles by this author , Marco SandriMarco Sandri More articles by this author , Travis RogersTravis Rogers More articles by this author , and Vipul PatelVipul Patel More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003319.03AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Global cancer incidence ranks Prostate Cancer (CaP) as the second highest overall, with Africa and the Caribbean having the highest mortality. Previous literature suggests disparities in CaP outcomes according to ethnicity, specifically functional and oncological are suboptimal in black men. However, recent data shows black men achieve post radical prostatectomy (RP) outcomes equivalent to white men in a universally insured system. Our objective is to compare outcomes of patients who self-identified their ethnicity as black or white undergoing RP at our institution. METHODS: From 2008 to 2017, 396 black and 4929 white patients underwent primary robotic-assisted radical prostatectomy (RARP) with a minimum follow-up of 5 years. Exclusion criteria were concomitant surgery and cancer status not available. A propensity score (PS) match was performed with a 1:1, 1:2, and 1:3 ratio without replacement. Primary endpoints were potency, continence recovery, biochemical recurrence (BCR), positive surgical margins (PSM), and post-operative complications. RESULTS: After PS 1:1 matching, 341 black vs. 341 white men with a median follow-up of approximately 8 years were analyzed. The overall potency and continence recovery at 12 months was 52% vs 58% (p=0.3) and 82% vs 89% (p=0.3), respectively. PSM rates was 13.4 % vs 14.4% (p=0.75). Biochemical recurrence and persistence PSA was 13.8% vs 14.1% and 4.4% vs 3.2% respectively (p=0.75).Clavien-Dindo complications (p=0.4) and 30-day readmission rates (p=0.5) were similar. CONCLUSIONS: In our study, comparing two ethnic groups with similar preoperative characteristics and full access to screening and treatment showed compatible RARP results. We could not demonstrate outcomes superiority in one group over the other. However, this data adds to the growing body of evidence that the racial disparity gap in prostate cancer outcomes can be narrowed if patients have appropriate access to prostate cancer management. It also could be used in counseling surgeons and patients on the surgical intervention and prognosis of prostate cancer in patients with full access to gold standard screening and treatment. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e853 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jonathan Noel More articles by this author Marcio Moschovas More articles by this author Abdel Rahman Jaber More articles by this author Marco Sandri More articles by this author Travis Rogers More articles by this author Vipul Patel More articles by this author Expand All Advertisement PDF downloadLoading ...